Literature DB >> 23295582

Novel topical formulations of Terbinafine-HCl for treatment of onychomycosis.

Sakine Tuncay Tanrıverdi1, Özgen Özer.   

Abstract

Terbinafine hydrochloride (TBF-HCl) is an active substance that is using for treatment of onychomycosis. Onychomycosis is a fungal infection which is the most common disease of nail plate. The nail plate is a barrier which prevents effective topical treatment of ungual disorders. In this study, TBF-HCl loaded liposome and ethosome formulations and also gel form of these formulations were prepared. The formulations were characterized and in vitro and ex vivo release studies were performed. Nail characterization studies were also performed to examine the effect of formulations and experimental conditions on nail surface. As a result, all formulations can serve as efficient formulations for ungual application of TBF-HCl. By the way, the results of the accumulation studies suggested that liposome poloxamer gel formulation could be promising system for ungual drug delivery due to the better accumulation and easier application of the formulation.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23295582     DOI: 10.1016/j.ejps.2012.12.014

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  11 in total

Review 1.  Mechanistic Insights of Formulation Approaches for the Treatment of Nail Infection: Conventional and Novel Drug Delivery Approaches.

Authors:  Agrawal Vikas; Patel Rashmin; Patel Mrunali; Rahul B Chavan; Thanki Kaushik
Journal:  AAPS PharmSciTech       Date:  2020-01-14       Impact factor: 3.246

2.  Ultraflexible lipid vesicles allow topical absorption of cyclosporin A.

Authors:  Juan J Carreras; Willian E Tapia-Ramirez; Adrian Sala; Antonio J Guillot; Teresa M Garrigues; Ana Melero
Journal:  Drug Deliv Transl Res       Date:  2020-04       Impact factor: 4.617

3.  Preparation and Characterization of Caffeine Loaded Liposome and Ethosome Formulations for Transungual Application.

Authors:  Sakine Tuncay Tanriverdi
Journal:  Turk J Pharm Sci       Date:  2018-07-17

4.  A novel transdermal nanoethosomal gel of betahistine dihydrochloride for weight gain control: in-vitro and in-vivo characterization.

Authors:  Shahira F El-Menshawe; Adel Ahmed Ali; Abdelkhalk Ali Halawa; Ahmed Sg Srag El-Din
Journal:  Drug Des Devel Ther       Date:  2017-11-28       Impact factor: 4.162

5.  In Vitro Antifungal Activity of Hexahydropyrimidine Derivatives against the Causative Agents of Dermatomycosis.

Authors:  Francislene J Martins; César A Caneschi; Mônica P Senra; Gustavo S G Carvalho; Adilson D da Silva; Nádia R B Raposo
Journal:  ScientificWorldJournal       Date:  2017-10-26

Review 6.  Novel Drug Delivery Strategies for the Treatment of Onychomycosis.

Authors:  Rupinder K Dhamoon; Harvinder Popli; Madhu Gupta
Journal:  Pharm Nanotechnol       Date:  2019

7.  The Potential of Caffeic Acid Lipid Nanoparticulate Systems for Skin Application: In Vitro Assays to Assess Delivery and Antioxidant Effect.

Authors:  Supandeep Singh Hallan; Maddalena Sguizzato; Markus Drechsler; Paolo Mariani; Leda Montesi; Rita Cortesi; Sebastian Björklund; Tautgirdas Ruzgas; Elisabetta Esposito
Journal:  Nanomaterials (Basel)       Date:  2021-01-12       Impact factor: 5.076

8.  Enhanced transdermal delivery of diclofenac sodium via conventional liposomes, ethosomes, and transfersomes.

Authors:  Saeed Ghanbarzadeh; Sanam Arami
Journal:  Biomed Res Int       Date:  2013-07-14       Impact factor: 3.411

Review 9.  Onychomycosis: Potential of Nail Lacquers in Transungual Delivery of Antifungals.

Authors:  Nida Akhtar; Hemlata Sharma; Kamla Pathak
Journal:  Scientifica (Cairo)       Date:  2016-03-30

10.  In vitro assessment of pharmaceutical potential of ethosomes entrapped with terbinafine hydrochloride.

Authors:  Syed Ahmed Iizhar; Ismail Ahmed Syed; Rukhsana Satar; Shakeel Ahmed Ansari
Journal:  J Adv Res       Date:  2016-03-15       Impact factor: 10.479

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.